Is Genpact Ltd. overvalued or undervalued?

As of 17 October 2025, the valuation grade for Genpact Ltd. has moved from attractive to fair, indicating a shift in its perceived value. Based on the current metrics, the company appears to be fairly valued. The P/E ratio stands at 14, while the EV to EBITDA ratio is 10.29, and the Price to Book Value is 3.09. In comparison, peers such as ICON plc and Booz Allen Hamilton Holding Corp. have P/E ratios of 14.64 and 15.81, respectively, suggesting that Genpact is positioned competitively within its industry.
Despite its fair valuation, Genpact has struggled in terms of stock performance, with a year-to-date return of -8.17%, significantly underperforming the S&P 500's return of 13.30% over the same period. This trend is further highlighted by a 3-year return of -12.78% compared to the S&P 500's impressive 81.19%, reinforcing the notion that while the stock may be fairly valued, it has not delivered strong returns relative to the broader market.